BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37562671)

  • 1. BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy.
    Wang S; Xu N; Wang J; Chen Y; Li W; Chen H; Shen C; Xu C; Wei X; Lu D; Qiu N; Zheng S; Wei Q; Xu X
    Cancer Lett; 2023 Sep; 571():216336. PubMed ID: 37562671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 marks the exhausted CD8
    Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
    Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
    Sasaki M; Ikeda H; Itatsu K; Yamaguchi J; Sawada S; Minato H; Ohta T; Nakanuma Y
    Lab Invest; 2008 Aug; 88(8):873-82. PubMed ID: 18591938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncAY controls BMI1 expression and activates BMI1/Wnt/β-catenin signaling axis in hepatocellular carcinoma.
    Chen MH; Fu LS; Zhang F; Yang Y; Wu XZ
    Life Sci; 2021 Sep; 280():119748. PubMed ID: 34174322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
    Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
    Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
    Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
    Qi S; Li B; Yang T; Liu Y; Cao S; He X; Zhang P; Li L; Xu C
    Int J Mol Sci; 2014 Nov; 15(11):20004-21. PubMed ID: 25372945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of KLRG1 and CD127 defines distinct CD8
    Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis.
    Li B; Chen Y; Wang F; Guo J; Fu W; Li M; Zheng Q; Liu Y; Fan L; Li L; Xu C
    Oncogene; 2020 Jan; 39(5):1063-1079. PubMed ID: 31591477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.
    Brunner SM; Rubner C; Kesselring R; Martin M; Griesshammer E; Ruemmele P; Stempfl T; Teufel A; Schlitt HJ; Fichtner-Feigl S
    Hepatology; 2015 Jun; 61(6):1957-67. PubMed ID: 25645298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
    Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.
    Bartucci M; Hussein MS; Huselid E; Flaherty K; Patrizii M; Laddha SV; Kui C; Bigos RA; Gilleran JA; El Ansary MMS; Awad MAM; Kimball SD; Augeri DJ; Sabaawy HE
    Target Oncol; 2017 Aug; 12(4):449-462. PubMed ID: 28589491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi1 is required for hepatic progenitor cell expansion and liver tumor development.
    Fan L; Xu C; Wang C; Tao J; Ho C; Jiang L; Gui B; Huang S; Evert M; Calvisi DF; Chen X
    PLoS One; 2012; 7(9):e46472. PubMed ID: 23029524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma.
    Wang R; Fan H; Sun M; Lv Z; Yi W
    Technol Cancer Res Treat; 2022; 21():15330338211070689. PubMed ID: 35072573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment.
    Wang S; Wang R; Xu N; Wei X; Yang Y; Lian Z; Cen B; Shen C; Li W; Wang J; Zhang Z; Tang L; Wei Q; Lu D; Xu X
    Hepatology; 2023 Oct; 78(4):1064-1078. PubMed ID: 36626623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic inflammatory IgA
    Sung PS; Park DJ; Roh PR; Mun KD; Cho SW; Lee GW; Jung ES; Lee SH; Jang JW; Bae SH; Choi JY; Choi J; Ahn J; Yoon SK
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.